Welcome to BioMarin's Online Press Room.
We've brought together a variety of information in one location
to better assist you in your efforts to research and develop
news articles. Should you require additional information, please
call or e-mail us any time.
BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio... MORE >BioMarin to Attend Upcoming Investor Conferences... MORE >Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Credit Suisse 2014 Healthcare Conference... MORE >